Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Governor Christie Names Aaron Fichtner as Acting Commissioner of Labor

Aaron Fichtner

Aaron Fichtner

Trenton, NJ, September 28, 2016 — Governor Chris Christie on September 23 announced the appointment of Aaron R. Fichtner, Ph.D., as Acting Commissioner of the Department of Labor and Workforce Development, adding that he will formally nominate Dr. Fichtner on Monday to succeed Commissioner Harold J. Wirths.

Dr. Fichtner has been a part of the Department since 2010, serving as Deputy Commissioner since 2012.

Governor Christie said, “The New Jersey Department of Labor and Workforce Development has come a long way during the past six years, reinventing our reemployment efforts during the darkest days of the recession to focus getting jobseekers trained for positions in the Garden State’s emerging and most promising industry clusters.” Continue reading

Event: Join HINJ for 2016 Life Sciences Celebration on October 6; Honorees Named

Celebration HINJNew Brunswick, NJ, September 27, 2016 ― Please join the HealthCare Institute of New Jersey (HINJ) for its 2016 Life Sciences Celebration honorees, which will be held Thursday, October 6 from 8:00 to 10:00 a.m. at the Historic Trenton Masonic Temple from 8:00 to 10:00 a.m.

HINJ’s 2016 honorees will be:

  • The Honorable Bob Franks Public Service AwardThe Honorable Herb Conaway, Jr., M.D., Member, New Jersey General Assembly, Chair, Health and Senior Services Committee

Sen. Diane Allen Bill Legalizing Telemedicine in New Jersey Passes Committee

Trenton Capital Dome  MoonTrenton, NJ, September 27, 2016 — Legislation sponsored by Senator Diane Allen (R-Burlington) authorizing the use of telemedicine in New Jersey has been advanced by the Senate Health Committee.

“Telemedicine is especially vital for patients who suffer from chronic illness, seniors who are homebound, and families who live in rural areas where they would have to travel very far to receive medical care,” Senator Allen said.

“No one should have to choose between paying for groceries and traveling to see a doctor,” Senator Allen continued.  “By legalizing telemedicine, we can bring the cost of healthcare down and expand access to a variety of health services for millions of new patients.” Continue reading

Tufts CSDD Report: Cost of Bringing New Drug to Market Surpasses $2.8 Billion.

Research 1Boston, MA, September 27, 2016 — The most recent analysis by the Tufts Center for the Study of Drug Development of the average cost to develop and gain marketing approval for a new drug — pegged at $2.558 billion — was published in the May 2016 issue of Journal of Health Economics.

The article contains more detailed analyses and discussion than were presented in November 2014 when Tufts CSDD first disclosed primary results on the cost of developing a new prescription medicine, after having previously submitted the study to the peer-reviewed publication.

The $2.558 billion figure per approved compound is based on estimated average out-of-pocket costs of $1.395 billion and time costs (expected returns that investors forego while a drug is in development) of $1.163 billion. Continue reading

U.S. Sees Sizable Increase in R&D Spending; Totals Rose by $20 Billion in 2014; Similar Increase Estimated for 2015

R&D 5Arlington, VA, September 26, 2016 — The National Science Foundation reports that U.S. research and development (R&D) performance rose to $477.7 billion in 2014 — an increase of $21.1 billion over the previous year — and is estimated to hit $499.3 billion in 2015, according to a new report from the National Center for Science and Engineering Statistics (NCSES).

The NCSES report looks at two different aspects of the U.S. system: the performance of R&D by businesses, government agencies, higher education institutions and other organizations, and the funding sources used by these sectors to perform that R&D.

R&D Performance

Adjusted for inflation, growth in U.S. total R&D performance averaged 1.2 percent annually between 2008 and 2014, matching the average pace of U.S. gross domestic product (GDP).  The NCSES data show increases of $20.4 billion in 2013, $21.1 billion in 2014 and an estimated $21.6 billion in 2015.

U.S. R&D performance breaks down into three categories: basic research ($84 billion of the 2014 total), applied research ($93.6 billion) and experimental development ($300.1 billion).

Federal funding accounted for 45 percent of basic research, 36 percent of applied research and 16 percent of development.

Business funding accounted for 27 percent of basic research, 52 percent of applied research and 82 percent of development.

The business sector is by far the largest performer of U.S. R&D, accounting for $340.7 billion, or 71 percent of the total in 2014. The sector has long been the predominant performer, with an annual share ranging between 68 percent and 74 percent over the past 20 years.

The higher education sector is the second-largest performer of R&D, with universities and colleges performing $64.7 billion, or 14 percent of the total in 2014. From 2012 to 2014, higher education annual increases dropped below $1 billion.

The federal government conducted $52.3 billion, or 11 percent, of U.S. R&D in 2014, of which $34.4 billion was performed by agencies in their own facilities, with the remainder performed at federally funded research and development centers (FFRDCs).

R&D Funding

The business sector was the largest funder of R&D, accounting for $318.6 billion of the 2014 total of $477.7 billion. Nearly all of the business sector’s funding — 98 percent — was directed at R&D performance by businesses.

The federal government was the second largest funder, at $119.8 billion.  The federal government directed $34.4 billion of its funding to R&D at agencies, $17.5 to FFRDCs, $26.6 billion to businesses and $34.1 billion to academic institutions.

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2016, its budget is $7.5 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions.

Each year, NSF receives more than 48,000 competitive proposals for funding and makes about 12,000 new funding awards. NSF also awards about $626 million in professional and service contracts yearly.

Rutgers President Robert Barchi Plans to Stay Beyond 5-Year Commitment

Robert Barchi, M.D., Ph.D.

Robert Barchi, M.D., Ph.D.

New Brunswick, NJ, September 25, 2016 ― Adam Clark reports in The Star-Ledger that when Rutgers University lured Robert Barchi, M.D., Ph.D. out of retirement to become its president in 2012, he told reporters he was making at least a five-year commitment to the university.

Now, in the midst of his fifth year at the helm of Rutgers, the 70-year-old is happier than ever with the state of the university and feels more energized than he has any point in his tenure, he told NJ Advance Media in an interview Wednesday.

“As of right now, I have no intention of stepping down this year,” Dr. Barchi said. “As long as I think we are on a positive trajectory… I am willing to continue in the job for a while.” Continue reading

Event: NJBIA to Host Second Annual Innovation Summit on November 2

Innovation button touch 2Trenton, NJ, September 25, 2016 ― The New Jersey Business & Industry Association (NJBIA) will host its Second Annual Innovation Summit on Wednesday, November 2 at the Princeton Plasma Physics Laboratory from 8:30 a.m. to 2:00 p.m.

The half day event will bring together thought leaders and feature both venture capitalists and internationally recognized CEOs who will tell their story on what it takes to cultivate innovation in a business.

The Summit, designed for both local startups and legacy corporations, also will highlight the resources our state’s six research universities and state and local government have to offer.  Continue reading

Event: Somerset County Business Partnership and HINJ to Present ‘Achieve a Healthier, More Productive Workforce’ Event on November 9

Workforce Healthy 2Bridgewater, NJ, September 24, 2016 — The Somerset County Business Partnership — in partnership with the HealthCare Institute of New Jersey (HINJ) and Healthier Somerset — will host “Achieve a Healthier, More Productive Workforce: The Value of Medication Adherence” breakfast event.

The event will be held on Wednesday, November 9 from 8:00 to 10:00 a.m. at the New Jersey Center of Excellence Bridgewater at 1041 U.S. Highway 202-206, Bridgewater, NJ 08807.

The breakfast event will feature a presentation by The Asheville Project creator John Miall, Jr.  The Asheville Project focuses on eliminating barriers to care, providing employees with the resources to maintain a healthy lifestyle, and engaging local pharmacists as partners in care.  Continue reading

Two Startups Based on Rutgers Inventions Chosen as Best University Startups; Showcased at U.S. Capitol

Rutgers 250 AnniversaryNew Brunswick, NJ, September 24, 2016 ― Two new companies built on Rutgers inventions were presented on September 20 at University Startup Demo Day, an event in the U.S. Capitol Building for members of Congress members and staff, as well as venture capitalists, angel investors and corporate representatives.

The two Rutgers spinouts are:

  • Celvive Inc., which is refining a stem-cell technology for regenerative medicine applications, such as helping patients recover from spinal cord injury.

NJHA’s Betsy Ryan to Step Down; First Woman CEO Led Organization Through ‘Transformative Time’ in Healthcare

Betsy Ryan

Betsy Ryan

Princeton, NJ, September 23, 2016 — New Jersey Hospital Association (NJHA) President and CEO Elizabeth “Betsy” Ryan, the first woman to lead the 98-year-old healthcare trade group, announced yesterday that she is stepping down after nine years at the Association’s helm.

Ryan’s resignation will be effective in July 2017.

“It has been a privilege to work with the healthcare provider community in New Jersey in taking good care of the people of our state,” said Ryan.

“My tenure has coincided with one of the most transformative times in healthcare history,” Ryan said.  “It’s not easy to step down from a meaningful, fulfilling job, but I do so knowing that I’ve accomplished what I wanted in my career at NJHA.  Change is good, and it’s the right time for me and my family.” Continue reading